Terms ending in 2038
Every in-force patent on Crititech, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,737,972 | Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles In force · Medium confidence | Crititech, Inc. | In force | Medium confidence | |
| US 12,128,131 | Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles In force · Low confidence | Crititech, Inc. | In force | Low confidence | |
| US 10,398,646 | Methods for Treating Lung Disorders In force · High confidence | Crititech, Inc. | In force | High confidence | |
| US 10,507,181 | Methods for Treating Lung Disorders In force · High confidence | Crititech, Inc. | In force | High confidence | |
| US 11,160,754 | Methods for Treating Lung Disorders In force · High confidence | Crititech, Inc. | In force | High confidence | |
| US 11,523,983 | Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles In force · Medium confidence | Crititech, Inc. | In force | Medium confidence | |
| US 11,104,663 | Ciprofloxacin Polymorph and Its Use In force · High confidence | Crititech, Inc. | In force | High confidence | |
| US 11,918,691 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer In force · Medium confidence | Crititech, Inc. | In force | Medium confidence | |
| US 12,329,858 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer In force · Medium confidence | Crititech, Inc. | In force | Medium confidence | |
| US 11,058,639 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer In force · High confidence | Crititech, Inc. | In force | High confidence | |
| 2 more term ends in 2038 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.